Efficacy and Safety of Sorafenib Versus Supportive Care in Egyptian Advanced Hepatocellular Carcinoma Patients

• Main Authors: Noha Salah El Baghdady (Author), Lamia Elwakeel (Author), Mahmoud Ellithy (Author), Nawal Hussein (Author), Sara Shahin (Author), Abdel Rahman El Naggar (Author)
• Format: Book
• Published: Ain Shams University, 2020-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives: Sorafenib is the standard first-line treatment for HCC. No sufficient data exists regarding its efficacy in the Egyptian population being a costly medication that is not endorsed by insurance and hence is not used in most institutions. This study aimed to evaluate the overall survival [O...